Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Crypto

Biotech Firms Turn to Cryptocurrencies to Boost Stock Prices Amid Funding Challenges

by Team Lumida
August 26, 2025
in Crypto
Reading Time: 3 mins read
A A
0
Bitcoin Plunges to $64K Amid U.S. Tech Stock Turmoil

"Nobody gets me Bitcoins!" by zcopley is licensed under CC BY-SA 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

Powered by lumidawealth.com

  • At least 10 small biotech companies have pivoted to digital assets in 2025, using cryptocurrencies to revive flagging shares and attract investor interest.
  • Examples include ETHZilla (formerly 180 Life Sciences), which accumulated over $350 million in Ether tokens, and Sonnet BioTherapeutics, which surged 243% on plans to become a public crypto treasury.
  • These moves often lead to short-lived stock spikes but reflect deeper struggles in biotech funding and innovation pipelines.
  • Industry experts view crypto pivots as a last-ditch effort by management to justify their existence amid stalled drug development and funding shortages.
  • The Nasdaq Biotechnology Index has fallen about 13% since 2021, while the broader S&P 500 has risen 46%, highlighting biotech’s underperformance.
  • Raising capital through traditional means has become harder, with IPOs and fund inflows declining significantly in the sector.
  • Crypto investments carry risks, including stock price volatility tied to crypto market swings and potential alienation of core biotech investors.
  • Some companies, like Riot Platforms, have seen sustained gains after pivoting to crypto, but overall success remains limited.

What’s Happening?

Struggling biotech firms are increasingly turning to cryptocurrencies as a strategy to boost stock prices and attract capital amid a challenging funding environment and stalled drug pipelines. This trend reflects broader sector difficulties and investor skepticism.

Why Does It Matter?

The crypto pivot highlights the financial pressures biotech companies face and raises questions about the sustainability of such strategies. It also signals potential volatility for investors and the need for clearer paths to innovation and growth in biotech.

What’s Next?

Investors will watch how these crypto-biotech hybrids perform and whether the trend continues or fades. The sector’s recovery depends on renewed drug development success and improved funding conditions.

Source
Previous Post

Trump Says U.S. Holds Greater Leverage Over China on Rare Earth Magnets Amid Trade Talks

Next Post

Trump Calls for European Troops in Ukraine; Public and Political Support Across Europe Is Tepid

Recommended For You

Saylor Hikes Preferred Yields to Keep Bitcoin-Funding Engine Running

by Team Lumida
9 hours ago
Saylor Hikes Preferred Yields to Keep Bitcoin-Funding Engine Running

Key Takeaways Powered by lumidawealth.com Strategy Inc. (Michael Saylor) is raising the coupon on its preferred shares—its primary funding vehicle—to revive soft demand. Move signals a higher cost of...

Read more

Binance Aid to Trump Family Crypto Preceded CZ Pardon, Supercharging USD1

by Team Lumida
1 day ago
Binance Aid to Trump Family Crypto Preceded CZ Pardon, Supercharging USD1

Key Takeaways Powered by lumidawealth.com Binance helped build World Liberty’s USD1 stablecoin and facilitated a $2 billion USD1-funded stake sale to Emirati investor MGX, lifting USD1’s market cap above...

Read more

Polymarket Plans US Return Within Weeks With Sports Focus

by Team Lumida
2 days ago
Polymarket Plans US Return Within Weeks With Sports Focus

Key Takeaways Polymarket preparing US return by end of November with sports betting focus; initial trading won't be broadly available. Launch would cap turnaround after being kicked offshore,...

Read more

PBOC Governor Warns on Stablecoin Risks as Global Anxiety Builds

by Team Lumida
3 days ago
Bitcoin Mining Stocks Outperform BTC in Early 2025, Network Strength Grows

Key Takeaways Powered by lumidawealth.com PBOC Governor Pan warned stablecoins fail customer ID/AML requirements, "foster market speculation," increase global financial fragility, and threaten monetary sovereignty of less-developed economies. China...

Read more

Stablecoin Payments Accelerate After U.S. Regulatory Clarity

by Team Lumida
4 days ago
Bitcoin Could Drop to $50K Before a Potential Fed-Driven Rally

Key Takeaways Powered by lumidawealth.com Stablecoin transaction volume for payments hit $10B in August, up 70% since February and more than 2x YoY. Business-to-business payments dominate at $6.4B monthly...

Read more

Tether Targets $15 Billion Profit and $500 Billion Valuation as Stablecoin Dominance Grows

by Team Lumida
6 days ago
a close up of a pile of crypt coins

Key Takeaways: Powered by lumidawealth.com Tether expects nearly $15 billion in 2025 profit, up from $13 billion last year, driven by high interest income on U.S. Treasuries. The company...

Read more

JPMorgan to Allow Bitcoin and Ether as Collateral in Crypto Push

by Team Lumida
1 week ago
Tax-Loss Harvesting Surge: JPMorgan’s $15 Billion Windfall

Key Takeaways JPMorgan will allow institutional clients to use Bitcoin and Ether as loan collateral by end-2025, relying on third-party custodian; builds on earlier move to accept crypto...

Read more

Crypto Leaders Hit Capitol Hill to Push Market Structure Bill

by Team Lumida
1 week ago
Crypto Leaders Hit Capitol Hill to Push Market Structure Bill

Key Takeaways Powered by lumidawealth.com ~12 crypto CEOs (Coinbase's Armstrong, Kraken's Ripley, Uniswap's Adams, Chainlink's Nazarov) met Senate leaders (Banking Chair Tim Scott, Schumer, Gillibrand) for ~3 hours Wednesday...

Read more

Altcoins Stuck Below Post-FTX Low as Crypto Risk Appetite Sinks

by Team Lumida
1 week ago
Altcoins Stuck Below Post-FTX Low as Crypto Risk Appetite Sinks

Key Takeaways Powered by lumidawealth.com A ~$20B Oct. 10 liquidation triggered crypto’s largest single-day washout; altcoin index of 50 smallest tokens now trades below 2022 FTX-era lows, signaling retreat...

Read more

BlackRock Is Pulling Bitcoin Whales Into Wall Street’s Orbit

by Team Lumida
1 week ago
Is BlackRock the New Leader in Alternative Investments?

Key Takeaways Powered by lumidawealth.com In-kind creations for spot Bitcoin ETFs, approved in July, let large holders swap BTC for ETF shares without a taxable sale, moving assets onto...

Read more
Next Post
Trump Tariffs Leave Key Questions on China Supply Chain Rules Unanswered

Trump Calls for European Troops in Ukraine; Public and Political Support Across Europe Is Tepid

Microsoft’s Blue Screen of Death: What You Need to Know

Microsoft Probes Employee Occupation of Brad Smith’s Office Over Israel–Gaza Concerns

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

OpenAI Fixed ChatGPT Security Flaw That Put Gmail Data at Risk

October 13, 2025
Trump Tariffs Leave Key Questions on China Supply Chain Rules Unanswered

Epstein Letter Allegedly From Trump Released by House Democrats

September 9, 2025
A person holding a cell phone in their hand

DeepSeek’s Founder Rejects Quick Cash, Prioritizes Vision Over Profit

March 11, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018